The increased mortality associated with erythropoietin treatment in cancer patients reported by Henke et al (2003); Leyland-Jones et al (2005), and more recently in studies by Overgaard et al (2007); Wright et al (2007); Smith et al (2008), is not supported by the present meta-analysis. This evidence concerns the gene EPO and cancer.